Concurrent increased high sensitivity C-reactive protein and chronic infections are associated with coronary artery disease: A population-based study

Indian Journal of Medical Sciences

Volumn 61, Issue 3, 2007, Pages 135-143

  Vahdat, Katayon ^a   Jafari, Seyed Mojtaba ^a   Pazoki, Raha ^a   Nabipour, Iraj ^a  

^a BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

C reactive protein; Chlamydia pneumoniae; Coronary artery disease; Cytomegalovirus; Helicobacter pylori; Herpes simplex virus

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODY DETECTION; ARTICLE; CARDIOVASCULAR RISK; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SEX RATIO; STATISTICAL SIGNIFICANCE;

EID: 33847794596     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5359.30748     Document Type: Article

References (21)

1. Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem 2004;279:48487-90.
2. Jialal I, Devaraj S, Venugopal SK. C-reactive protein: Risk marker or mediator in atherothrombosis? Hypertension 2004;44:6-11.
3. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-9.
4. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease-application to clinical and public health practice. Circulation 2003;107:499-511.
5. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al. Low grade inflammation and coronary heart disease: Prospective study and updated meta-analyses. BMJ 2000;321:199-204.
6. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.
7. Romano Carratelli C, Nuzzom I, Cozzolino D, Bentivoglio C, Paolillo R, Rizzo A. Relationship between Chlamydia pneumoniae infection, inflammatory markers and coronary heart diseases. Int Immunopharmacol 2006;6:848-53.
8. Corrado E, Rizzo M, Tantillo R, Muratori I, Bonura F, Vitale G, et al. Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: A 5-year follow-up. Stroke 2006;37:482-6.
9. Rupprecht HJ, Blankenberg S, Bickel C, Rippin G, Hafner G, Prellwitz W, et al. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 2001;104:25-31.
10. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
11. Prineas RJ, Crowe RS, Blackburn H. The Minnesota Code manual of electrocardiographic findings. Bristol: John Wright; 1982.
12. Rose R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999;340:115-26.
13. Corrado E, Novo S. Role of inflammation and infection in vascular disease. Acta Chir Belg 2005;105:567-79.
14. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-97.
15. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, et al. Inflammatory markers and risk of coronary heart disease in men and women. N Engl J Med 2004;351:2599-610.
16. Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, Oberhollenzer F, et al. Chronic infections and the risk of carotid atherosclerosis: Prospective results from a large population study. Circulation 2001;103:1064-70.
17. Mayr M, Kiechl S, Willeit J, Wick G, Xu Q. Infection, immunity and atherosclerosis: association of antibodies to Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 2000;102:833-9.
18. Zhu J, Quyyumi AA, Norman JE, Csako G, Waclawiw MA, Shearer GM, et al. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol 2000;85:140-6.
19. Huittinen T, Leinonen M, Tenkanen L, Virkkunen H, Manttari M, Palosuo T, et al. Synergistic effect of persistent Chlamydia pneumoniae infection, autoimmunity and inflammation on coronary risk. Circulation 2003;107:2566-70.
20. Muhlestein JB, Horne BD, Carlquist JF, Madsen TE, Bair TL, Pearson RR, et al. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographyically demonstrated coronary artery disease. Circulation 2000;102:1917-23.
21. Johnston CJ, Messina LM, Browner WS, Lawton MT, Morris C, Dean D. C-reactive protein levels and viable Chlamydia pneumoniae in carotid artery atherosclerosis. Stroke 2001;32:2748-52.